Eric H.‐B. Huang

Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer

Zachary A. Yochum, Jessica Cades, Hailun Wang et al. · Oncogene · 2018 · 186 citations · Full text

Medicine, Molecular Biology, Oncology +15

Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers

Aaron Prodeus, Aws Abdul‐Wahid, Nicholas W. Fischer et al. · Molecular Therapy — Nucleic Acids · 2015 · 144 citations · Full text

Medicine, Oncology, Pharmacology +17

A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer

Zachary A. Yochum, Jessica Cades, Lucia Mazzacurati et al. · Molecular Cancer Research · 2017 · 92 citations

Medicine, Oncology, Pharmacology +14

Induction of antigen‐specific T_H9 immunity accompanied by mast cell activation blocks tumor cell engraftment

Aws Abdul‐Wahid, Marzena Cydzik, Aaron Prodeus et al. · International Journal of Cancer · 2016 · 49 citations

Medicine, Immunology, Oncology +17

Acquired Resistance to the Hsp90 Inhibitor, Ganetespib, in <i>KRAS-</i> Mutant NSCLC Is Mediated via Reactivation of the ERK–p90RSK–mTOR Signaling Network

Suman Chatterjee, Eric H.‐B. Huang, Ian Christie et al. · Molecular Cancer Therapeutics · 2017 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17